GLP-1 Drugs Powered IHE's Big Year. IXJ Is Playing a Longer Game.

iShares U.S. Pharmaceuticals ETF offers concentrated exposure to domestic drug manufacturers, while iShares Global Healthcare ETF provides broader exposure to more than 100 companies across the global healthcare sector. The article is descriptive and compares fund composition rather than reporting a material catalyst, earnings event, or policy change. Market impact is likely minimal.

Analysis

iShares U.S. Pharmaceuticals ETF offers concentrated exposure to domestic drug manufacturers, while iShares Global Healthcare ETF provides broader exposure to more than 100 companies across the global healthcare sector. The article is descriptive and compares fund composition rather than reporting a material catalyst, earnings event, or policy change. Market impact is likely minimal.